Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04363684 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 years 2 months later Jun 30, 2026 → Aug 31, 2030
Primary endpoint reworded 1 of 3 changed
See other at-risk trials from Mayo Clinic

Record History

  1. Study sites: 27 to 26 Publications: details revised at 1 of 1 entry · Eligibility criteria expanded, about 4 words Show 2 more changesShow less
    • Publications: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 4 words
  2. Primary and study completion pushed from Jun 30, 2026 to Aug 31, 2030 Primary endpoint(s) modifiedv14 Show 1 more changeShow less
    • Primary endpoint(s) modified

    See this version in full on ClinicalTrials.gov ↗

  3. Primary and study completion dates: Jun 2025 to Jun 30, 2026v13
  4. Study sites revised (27)v12 See this version in full on ClinicalTrials.gov ↗
  5. Primary and study completion dates: Jul 2024 to Jun 2025 Site contacts updated at 1 of 27 sitesv11 Show 1 more changeShow less
    • Site contacts updated at 1 of 27 sites
Show 9 earlier versionsHide 9 earlier versions
  1. Study sites: 26 to 27v10
  2. Study sites: 23 to 26v9
  3. Site contacts updated at 3 of 23 sitesv8
  4. Site contacts updated at 4 of 23 sitesv7
  5. Site contacts updated at 1 of 23 sitesv6
  6. Site details revised at 9 of 23 sitesv5
  7. Study sites: 19 to 23v4
  8. Site contacts updated at 1 of 19 sitesv3
  9. Site contacts updated at 6 of 19 sitesv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mayo Clinic
1,019 trials monitored
See 121 trials at risk
Dementia
920 trials monitored
See 46 trials at risk
ALS
387 trials monitored
See 18 trials at risk
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD for 2019 and beyond.
Trial Details
NCT Number NCT04363684
Lead Sponsor Mayo Clinic
Collaborators: University of California, San Francisco, National Institute on Aging (NIA), National Institute of Neurological Disorders and Stroke (NINDS)
Conditions Frontotemporal Lobar Degeneration (FTLD), Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), Behavioral Variant Frontotemporal Dementia (bvFTD), Semantic Variant Primary Progressive Aphasia (svPPA), Nonfluent Variant Primary Progressive Aphasia (nfvPPA), FTD With Amyotrophic Lateral Sclerosis (FTD/ALS), Amyotrophic Lateral Sclerosis +6 more
Enrollment 2,100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov